Question: is agomelatine approved by fda?
Answer: Agomelatine was first approved for clinical use in the European Union in 2009,11 where it is marketed under the names Valdoxan™ or Thymanax. Novartis, who purchased the marketing rights from Servier, is currently seeking United States Food and Drug Administration (FDA) approval for the drug in the United States.